NEW YORK (GenomeWeb) – Natera and Belgian cancer reference center Institut Jules Bordet plan to collaborate on a breast cancer research project using Natera's circulating tumor DNA assay, Signatera.

Natera will analyze around 300 plasma samples prospectively collected from 80 patients diagnosed with non-metastatic breast cancer who were all treated with chemotherapy followed by surgery.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.